Objective To analyze the clinical results of the medical aural and encephalic(EC) glue to mend the traumatic liver break.Methods 34 patients of traumatic liver breaks were divided into the comparison and research groups randomly.The control group was cured by traditional remending operation and the experiment group was cured by EC remedy.Results The mortality of operation was 30% and the rate of postoperative bleeding was 40% in the control group.While no complication happened,it had significant difference(P

Objective To evaluate effects of different starting dose methylprednisolone on acute exacerbations of chronic obstructive pulmonary disease(AECOPD).Methods 40 patients with AECOPD were allocated two groups in random,including group A(n=20,120mg methylprednisolone)and groups B(n=20,80mg methylprednisolone),with duration of treatment was 7 days respectively.Clinical sign and symptom,dyspnea score and arterial blood gases were measured and observed at 0-hour,72-hour,day 7.Results The group A was surperior to the group B in clinical efficacy.The differences of dyspnea score and arterial blood gases at 72-hour are significant between the two groups(P

Objective To study the clinical features of pulmonary Langerhans cell histiocytosis.Methods Restrospectively review of 7 cases of pulmonary Langerhans cell histiocytosis proved by pathology with the clinical,physical,radiological,pathological and pulmonary function presentation.Results Seven cases were all male,aged from 17 to 37.Four of them are cigarette smokers.The major symptoms were cough and laboring dyspnea,and pneumothorax presented in five cases.As to pulmonary function presentation,obstructive pattern presented in three cases,restrictive pattern and mixed pattern presented in two cases respectively,and the carbon monoxide diffusing capacity was decreased in four cases.The abnormalities present predominantly in the upper and middle lung fields on chest high-resolution CT scan.Lung cysts and reticular changes presented in six cases and nodules presented only in one case.The diagnosis was established by surgical lung biopsy.The positive cases of staining for the S-100,CD1a antigens,and CD68 were 7/7,4/5 and 5/6 respectively.Conclusion PLCH patients are typically young adults,often present with cough,laboring dyspnea and pneumothorax.Pulmonary function presentation is nonspecific and the carbon monoxide diffusing capacity may be decreased.The characteristic features of HRCT are bilateral reticulonodular areas and cysts change that predominantly involved the upper and middle lung zones with relative sparing of the lung bases.The pathologic feathers are interstitial infiltration of bronchiole walls and epithelium by LCH cells and cyst formation.The staining for CD1a antigens and the S-100 proteins is positive by immunohistochemical analysis.

Objective To explore the effect and its clinical significance of different dose of glucocorticoids on inflammation mediators in patients with acute exacerbation of chronic obstructive pulmonary diseases.Methods 45 patients admitted to our hospitals from March 2007 to March 2011 were randomly divided into 3 groups:methylprednisolone 40 mg group (methylprednisolone 40mg,iv,qd),methylprednisolone 80 mg group (methylprednisolone 80mg,iv,bid),and control group (without any glucocorticoids).The changes of dyspnea scores,arterial blood gas analysis,clinical symptom scores and serum IL-6,IL-8 and tumor necrosis factor (TNF) levels were detected in patients of each group before and at the 7th day after treatment.The related adverse drug reactions were recorded.Results The improvements in clinical symptom scores,Borg scores,PaCO2,PaO2 after treatment were higher in methylprednisolone 40 mg group and methylprednisolone 80 mg group than in control group (F=3.6747.162 and 42.88,respectively,P＜0.01 or 0.001),and the above improvements was better in methylprednisolone 80 mg group than in methylprednisolone 40 mg group (all P＜0.05).The decreases in levels of serum IL-8,TNF-α,IL-6,C-RP after the treatment were more significant in methylprednisolone 40 mg group and methylprednisolone 80 mg group than in control group (F=12.65,16.17,30.99,respectively,all P＜0.001),and the decrements were more significant in methylprednisolone 80 mg group than in methylprednisolone 40 mg group(all P＜0.05).NO serious adverse drug reactions happened during the course of treatment in the three groups.Conelusions Short-term and moderate dose of glucocorticoid treatment is effective and safe in treating the patients with acute exacerbation of chronic obstructive pulmonary diseases.Methylprednisolone 80 mg injection daily can more obviously improve AECOPD symptoms,and reduce the levels of inflammatory factors better.

Objective To evaluate the role of transbrochial needle aspiration (TBNA) in the diagnosis of patients with enlarged mediastinal and/or hilar lymph node. Methods Patients with mediastinal and/or hilar lymphoadenopathy proven by CT scan were eligible for TBNA as reported. All specimens were directly and instantly smeared for pathological examination. Results From June 1 2004 to December 31 2007, 164 patients were examined: including 80 lung cancers, 69 lung bengin diseases, 2 other malignancy tumor, and 13 without definite diagnosis. Total 260 lymph nodes were punctured. TBNA procedures were successfully carried out in 445/463(96.1%). Sensitivity of TBNA was 82. 5 % (66/80) in patients who had been proven to suffer from bronchogenic carcinoma. There were 25 patients that diagnosis of lung cancer was pathologically determined by TBNA only. A total of 122 lymph nodes in the 80 lung cancer patients were aspirated by TBNA with a positive rate of 65. 6% (80/122). Severe complications were rare except small amount of bleeding at the TBNA site (100/164, 61.0%). From June 1 2006 to December 31 2007, lymph node tissues able to make histology diagnosis were yield in 73.5% (64/87) patients. Through histology pathology, the sensitivities of TBNA were 53. 3% (8/15) for sarcoidosis and 78.6% (33/42) for lung cancer. Conclusion TBNA is quite safe and helpful in diagnosis and staging of bronchogenic carcinoma, and in diagnosis of benign lung diseases.

Objective    To compare the mortality in lung cancer patients infected with coronavirus disease 2019 (COVID-19) versus other cancer patients infected with COVID-19. Methods    A computer search of PubMed, EMbase, The Cochrane Library, Web of Science, Wanfang database, VIP database and CNKI database was conducted to compare the mortality of lung cancer and other cancers patients infected with COVID-19 from the inception to December 2021. Two thoracic surgeons independently screened the literature, extracted data, and then cross-checked the literature. After evaluating the quality of the included literature, a meta-analysis was performed on the literature using Review Manager 5.4 software. Results    A total of 12 retrospective cohort studies were included, covering 3 065 patients infected with COVID-19, among whom 340 patients suffered from lung cancer and the remaining 2 725 patients suffered from other cancers. Meta-analysis results showed that the lung cancer patients infected with COVID-19 had a higher mortality (OR=1.58, 95%CI 1.24 to 2.02, P<0.001). Subgroup analysis results showed that the mortality of two groups of patients in our country was not statistically different (OR=0.90, 95%CI 0.49 to 1.65, P=0.72). Whereas, patients with lung cancer had a higher mortality than those with other cancers in other countries (Brazil, Spain, USA, France, Italy, UK, Netherlands) (OR=1.78, 95%CI 1.37 to 2.32, P<0.001). Conclusion    There is a negligible difference in mortality between lung cancer and other cancers patients who are infected with COVID-19 in our country; while a higher mortality rate is found in lung cancer patients in other countries. Consequently, appropriate and positive prevention methods should be taken to reduce the risk of infecting COVID-19 in cancer patients and to optimize the management of the infected population.